# Aidoc

> Aidoc sells clinical AI software to hospitals and health systems. Its aiOS platform connects imaging analysis, clinical notifications, care coordination and follow-up workflows, while its CARE foundation model powers regulated imaging applications. Aidoc reported deployment in nearly 2,000 hospitals worldwide in 2026.

- **Founded:** 2016
- **Headquarters:** New York, United States
- **Founders:** Elad Walach (Co-founder and CEO), Michael Braginsky (Co-founder and CTO), Guy Reiner (Co-founder and Chief Architect), Gal Yaniv (Co-founder; Physician Executive)
- **Products:** aiOS, CARE, CARE Multi-Triage CT Body, Care Coordination, Patient Management
- **Notable:** FDA clearance for CARE Multi-Triage CT Body, announced January 2026., Reported nearly 2,000 hospital deployments and about 60 million cases analyzed annually in 2026., Reported more than 150 million patient cases analyzed cumulatively by August 2026.

## Products & services

- **aiOS** — Enterprise clinical AI deployment and orchestration platform connecting imaging, clinical workflows, third-party algorithms and monitoring. Originally announced in 2021.
- **CARE** — Clinical AI Reasoning Engine foundation model; CARE1 was introduced in 2024 and powers FDA-cleared applications.
- **CARE Multi-Triage CT Body** — FDA-cleared triage device; January 2026 commercial workflow brings 11 newly cleared indications together with three previously cleared indications. Supports trained clinicians and does not replace diagnostic interpretation.
- **Care Coordination** — Notifications and communication tools that connect radiology with multidisciplinary teams, including pulmonary embolism and stroke pathways.
- **Patient Management** — Tools to identify and track patients needing follow-up after actionable findings.
- **First Read** — Chest X-ray report-drafting technology received FDA Breakthrough Device Designation in June 2026; designation is not marketing clearance.

## Achievements

- FDA clearance for CARE Multi-Triage CT Body, announced January 2026.
- Reported nearly 2,000 hospital deployments and about 60 million cases analyzed annually in 2026.
- Reported more than 150 million patient cases analyzed cumulatively by August 2026.
- CARE Body CT Multi-Triage became eligible for Medicare NTAP for qualifying inpatient use from October 1, 2026.

## Latest updates

- **2026-08** — August 25: Mercy and Aidoc released findings on deployment and care improvements with an AVIA white paper.
- **2026-08** — August 13: announced Medicare NTAP eligibility for CARE Body CT Multi-Triage, effective October 1, 2026 for qualifying inpatient cases.
- **2026-08** — August 11: launched the Diagnostic AI Consortium with 12 U.S. health systems.
- **2026-06** — June 25: First Read report-drafting technology received FDA Breakthrough Device Designation.
- **2026-04** — April 29: announced US$150 million Series E.
- **2026-01** — January 21: announced FDA clearance expanding comprehensive CT triage.

## Links

- Website: https://www.aidoc.com/
- LinkedIn: https://www.linkedin.com/company/aidoc/
- Twitter/X: https://twitter.com/aidocmed
- Instagram: https://www.instagram.com/aidocmed/
- Facebook: https://www.facebook.com/aidocmed/

---

Profile page: https://yespress.io/aidoc
Published by YesPress — https://yespress.io
Last updated: 2026-10-16